These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 25997377)
1. Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation. Pawar SD; Murtadak VB; Kale SD; Shinde PV; Parkhi SS J Virol Methods; 2015 Sep; 222():28-33. PubMed ID: 25997377 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum. King DJ Avian Dis; 1991; 35(3):505-14. PubMed ID: 1835374 [TBL] [Abstract][Full Text] [Related]
3. The inactivation of avian influenza virus subtype H5N1 isolated from chickens in Thailand by chemical and physical treatments. Wanaratana S; Tantilertcharoen R; Sasipreeyajan J; Pakpinyo S Vet Microbiol; 2010 Jan; 140(1-2):43-8. PubMed ID: 19632071 [TBL] [Abstract][Full Text] [Related]
4. Receptor specificity and erythrocyte binding preferences of avian influenza viruses isolated from India. Pawar SD; Parkhi SS; Koratkar SS; Mishra AC Virol J; 2012 Oct; 9():251. PubMed ID: 23110802 [TBL] [Abstract][Full Text] [Related]
5. Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals. Swayne DE; Avellaneda G; Mickle TR; Pritchard N; Cruz J; Bublot M Avian Dis; 2007 Sep; 51(3):697-704. PubMed ID: 17992929 [TBL] [Abstract][Full Text] [Related]
6. Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production. Herrera-Rodriguez J; Signorazzi A; Holtrop M; de Vries-Idema J; Huckriede A Vaccine; 2019 Mar; 37(12):1630-1637. PubMed ID: 30765167 [TBL] [Abstract][Full Text] [Related]
7. Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products. Ito H; Ito T; Hikida M; Yashiro J; Otsuka A; Kida H; Otsuki K Dermatology; 2006; 212 Suppl 1():115-8. PubMed ID: 16490988 [TBL] [Abstract][Full Text] [Related]
8. Use of embryonated chicken egg as a model to study the susceptibility of avian influenza H9N2 viruses to oseltamivir carboxylate. Tare DS; Pawar SD J Virol Methods; 2015 Nov; 224():67-72. PubMed ID: 26297959 [TBL] [Abstract][Full Text] [Related]
9. In vitro inactivation of two Egyptian A/H5N1 viruses by four commercial chemical disinfectants. Marzouk E; Abd El-Hamid HS; Awad AM; Zessin KH; Abdelwhab EM; Hafez HM Avian Dis; 2014 Sep; 58(3):462-7. PubMed ID: 25518443 [TBL] [Abstract][Full Text] [Related]
10. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus. Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723 [TBL] [Abstract][Full Text] [Related]
11. Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. Jonges M; Liu WM; van der Vries E; Jacobi R; Pronk I; Boog C; Koopmans M; Meijer A; Soethout E J Clin Microbiol; 2010 Mar; 48(3):928-40. PubMed ID: 20089763 [TBL] [Abstract][Full Text] [Related]
12. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216 [TBL] [Abstract][Full Text] [Related]
13. Characterization of low-pathogenicity H5N1 avian influenza viruses from North America. Spackman E; Swayne DE; Suarez DL; Senne DA; Pedersen JC; Killian ML; Pasick J; Handel K; Pillai SP; Lee CW; Stallknecht D; Slemons R; Ip HS; Deliberto T J Virol; 2007 Nov; 81(21):11612-9. PubMed ID: 17728231 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite-textile materials. Imai K; Ogawa H; Bui VN; Inoue H; Fukuda J; Ohba M; Yamamoto Y; Nakamura K Antiviral Res; 2012 Feb; 93(2):225-233. PubMed ID: 22179064 [TBL] [Abstract][Full Text] [Related]
15. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Isoda N; Sakoda Y; Kishida N; Soda K; Sakabe S; Sakamoto R; Imamura T; Sakaguchi M; Sasaki T; Kokumai N; Ohgitani T; Saijo K; Sawata A; Hagiwara J; Lin Z; Kida H Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus. Sasaki Y; Yoshino N; Sato S; Muraki Y J Virol Methods; 2016 Sep; 235():105-111. PubMed ID: 27142111 [TBL] [Abstract][Full Text] [Related]
17. Phylogenetic and biological characterization of highly pathogenic H5N1 avian influenza viruses (Vietnam 2005) in chickens and ducks. Pfeiffer J; Pantin-Jackwood M; To TL; Nguyen T; Suarez DL Virus Res; 2009 Jun; 142(1-2):108-20. PubMed ID: 19428743 [TBL] [Abstract][Full Text] [Related]
18. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Shortridge KF; Zhou NN; Guan Y; Gao P; Ito T; Kawaoka Y; Kodihalli S; Krauss S; Markwell D; Murti KG; Norwood M; Senne D; Sims L; Takada A; Webster RG Virology; 1998 Dec; 252(2):331-42. PubMed ID: 9878612 [TBL] [Abstract][Full Text] [Related]
19. Low pathogenicity avian influenza viruses infect chicken layers by different routes of inoculation. Pantin-Jackwood MJ; Smith DM; Wasilenko JL; Spackman E Avian Dis; 2012 Jun; 56(2):276-81. PubMed ID: 22856182 [TBL] [Abstract][Full Text] [Related]
20. Development of broadly reactive H5N1 vaccine against different Egyptian H5N1 viruses. Ibrahim M; Sultan HA; Razik AG; Kang KI; Arafa AS; Shehata AA; Saif YM; Lee CW Vaccine; 2015 May; 33(23):2670-7. PubMed ID: 25910922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]